Barclays reiterates Tesla stock Equalweight rating at $360 target

Barclays maintained an Equalweight rating with a $360 price target while Tesla trades at $367.96 (~$1.38T market cap). Barclays warns capital expenditures could exceed $50B — potentially many multiples above the ~$20B the company earlier cited — as Tesla pursues a 1 terawatt Terafab project (funding potentially from Tesla and SpaceX/xAI). The NHTSA upgraded its probe to a detailed engineering analysis covering ~3.2 million vehicles, prompting GLJ to reiterate a Sell on FSD recall risk, while Morgan Stanley and Barclays sit at Equalweight and Stifel at Buy; Tesla’s balance sheet shows a current ratio of 2.16 and debt-to-equity of 0.18.

Analysis

Large, multi-year internal capital programs change the marginal winners: firms that sell high-performance compute, industrial automation and contract manufacturing scale much faster than raw-material suppliers when spending is phased and localized. Expect disproportionate revenue visibility for specialist server/AI hardware vendors over vertically integrated miners or commodity chemical names, because modular compute deployments are the easiest to accelerate or pause without stranding heavy assets.

Regulatory and execution risks create a bimodal return distribution for equity holders over 6–24 months. Near-term volatility will be driven by milestone readouts (quarterly guidance, engineering probes, and permit/phase approvals) while longer-term value depends on whether projects produce positive incremental returns before triggering equity or JV funding events. A credible near-term funding commitment from third parties would de-risk the equity path; conversely, any surprise recalls or engineering setbacks would materially compress implied multiples.

The consensus is focused on headline narratives; it underweights staging effects and financing optionality. Phased construction plus optional external funding tends to favor lenders and banks in the medium term while compressing ROIC for equity unless scale benefits crystallize quickly. This creates a multi-month window to harvest implied volatility and express a view with asymmetric instruments rather than outright directional exposure.

Key Decisions for Investors

• Pair trade (6–12 months): Short TSLA equity (size 1.0) / Long SMCI equity (size 0.6) — Rationale: play downside from execution/regulatory squeezes against upside in modular AI compute demand. Target asymmetry: 30–40% downside in TSLA vs 40–60% upside in SMCI; max drawdown risk ~12% on pair if TSLA outperforms.
• Options hedge (9–18 months): Buy TSLA 12-month put spread (sell nearer-dated put to fund) — cost-controlled downside protection with 3–4x payoff if a major regulatory/recall funding event drives >25% equity move. Position size: hedge 20–40% of concentrated exposure.
• Bank skew (3–9 months): Long MS or GS 6–12 month call/stock (choose the bank with better trading liquidity) — capture advisory/financing fee re-rate if external capital solutions are announced. Expect 15–25% IRR if M&A/advisory flows accelerate; protect with 12–15% stop-loss.
• Volatility trade (3–6 months): Buy straddle on TSLA around next major milestone (earnings or regulatory update) and sell after event-driven collapse in IV — short-term event trade to monetize elevated option premium with defined timebox.